Predictive Value of TGF-β1 and SMAD-7 Expression at Diagnosis for Treatment Response in Low-Risk Myelodysplastic Syndrome. Biomol Biomed 2025, 25 (5), 1175–1183. https://doi.org/10.17305/bb.2025.11564.